原发性肝癌三维适形放射治疗和介入治疗加放疗的疗效比较

The Comparison of the Efficacy between Three Dimensional Conformal Radiotherapy (3DCRT) alone and Transcatheter Arterial Chemoembolization (TACE) plus 3DCRT for Treatment of Unresectable Hepatacelluar Carcinoma

  • 摘要: 目的: 评价单纯三维适形放射治疗(3DCRT)与经皮肝动脉化疗栓塞术(TACE)结合3DCRT治疗不能手术的原发性肝癌(HCC)的疗效。 方法: 1999年1月至2001年10月,98例不能手术的HCC患者中,67例单纯3DCRT,31例TACE1~2次后3DCRT。放疗采用6MV射线,6Gy/次,隔日1次,总剂量54~60Gy;TACE采用超液态碘油、顺铂、吡喃阿霉素、丝裂霉素、明胶海绵颗粒经肝动脉化疗栓塞。 结果: 3DCRT组与3DCRT+TACE组近期有效率分别为83.6%、87.1%,1、2、3年生存率分别为89.6%、53.7%、22.4%和90.3%、51.6%、25.8%,两组差异无显著性(P0.05)。 结论: 3DCRT可作为非手术治疗HCC的有效方法之一。

     

    Abstract: Objective : To evaluate the therapeutic effects of three dimensional conformal radiation(3DCRT)and transcatheter arterial chemoembolization (TACE) combined with 3DCRT for the unresectable primary hepatacelluar carcinoma (HCC). Methods From January 1999 to October 2001, a total of 98 patients with HCC were treated. Sixty-seven of the 98 patients were treated with 3DCRT alone and 31 were treated with TACE plus 3DCRT. In the 3DCRT group, the total radiation dose 54~60Gy was given by 6MV X-ray, 6Gy each time and once every other day. In the 3DCRT+TACE group, TACE was given 1~2 times before 3DCRT.TACE was performed using lipiodol, cisplatin,perarubicin, mitomycin,followed by gelatin sponge cubes. Results : The efficacy rate for the 3DCRT group and the 3DCRT plus TACE group was 83.6% and 87.1%, respectively. The 1-, 2-, 3-year survival rate was 89.6%, 53.7% and 22.4%, and 90.3%, 51.6% and 25.8%, respectively. No significant difference for the efficacy rate or survival rate was found in the two groups (P0.05). Conclusion : The 3DCRT is effective and feasible and can be chosen as one of the first-line means in treating unresectable HCC.

     

/

返回文章
返回